Vancomycin-induced thrombocytopenia in a newborn

Area of Science:

• Neonatology
• Pharmacology
• Hematology

Background:

• Neonatal thrombocytopenia is a common clinical finding, frequently associated with neonatal sepsis.
• Drug-induced thrombocytopenia is often overlooked without a high index of suspicion.
• Failure to identify drug-induced thrombocytopenia can lead to prolonged antibiotic treatment and persistent low platelet counts in neonates.

Observation:

• A case of neonatal sepsis with concurrent vancomycin-induced thrombocytopenia is presented.
• Other potential causes of thrombocytopenia, including sepsis, alloimmune thrombocytopenia, and thrombosis, were systematically excluded.
• Platelet counts in the affected neonate normalized within 72 hours after discontinuation of vancomycin.

Findings:

• Vancomycin-induced neonatal thrombocytopenia is a rare but significant adverse drug reaction.
• The clinical presentation and exclusion of other causes support the diagnosis of vancomycin-induced thrombocytopenia.
• While vancomycin-induced IgM platelet antibodies were not assessed due to financial constraints, their absence does not rule out the diagnosis.

Implications:

• Clinicians should maintain a high index of suspicion for drug-induced thrombocytopenia in neonates, particularly those receiving vancomycin.
• Early recognition and cessation of the offending antibiotic are crucial for the management of vancomycin-induced thrombocytopenia.
• This case underscores the need for careful monitoring of platelet counts in neonates treated with vancomycin and consideration of alternative antibiotics if thrombocytopenia develops.